Двухнедельный обзор фондовых рынков №343. Возвращение «быков»

Astec Industries (ASTE) is an industrial manufacturer of equipment for road construction, asphalt mixing plants, aggregate (crushed stone) processing, and related construction‑materials production. The investment case is underpinned by a multi‑year infrastructure spending cycle in the U.S., where Astec holds a strong position as a key equipment supplier to road‑building and construction contractors. Another catalyst is the company’s recent acquisitions, which have expanded its footprint in materials processing and strengthened its service and parts businesses. This shift toward a higher mix of service and after-market revenue should stabilize results and reduce exposure to the cyclicality of new equipment sales. Besides, the company has been steadily improving operational efficiency, expanding margins, and maintaining a solid financial position despite higher leverage following M&A. Over the medium term, potential extensions of U.S. federal infrastructure programs, synergy realization from acquired assets, and continued mix improvement could drive further growth.

Freedom Broker analysts estimate a 12‑month fair price of $66 per share. 

 

Gentex Corporation (GNTX) is an automotive components and electronics manufacturer best known as the global leader in electrochromic auto-dimming rearview mirrors. But the investment case extends well beyond mirrors: Gentex is increasingly focused on higher-margin, more technologically advanced automotive electronics, including Full Display Mirror (FDM), driver and in-cabin monitoring systems, HomeLink, telematics, and connected-car solutions. We see the thesis driven by margin recovery, durable cash generation, and steadily rising component cost per vehicle. Additional upside could come from new product introductions and expansion beyond the legacy mirror business, while the shares currently trade at a reasonable valuation on several multiples. Key risks include dependence on global vehicle production, OEM customer concentration, tariff headwinds, and competition from camera-based and other alternative technologies.

Freedom Broker analysts assign a 12-month fair price of $28. 

 

iRadimed Corporation (IRMD) is a niche medical device manufacturer focused on MRI-compatible equipment, including infusion pumps, vital-sign monitors, and ferromagnetic detection systems. The investment case rests on the company’s unique position in a narrowly defined market with limited competition, high margins, and stable cash generation supported by a debt-free balance sheet. A key growth catalyst is the rollout of the MRidium 3870 infusion pump platform, which could trigger a multi-year replacement cycle at U.S. hospitals and support international expansion following approvals in Europe and Japan. Additional upside may come from growth in the security systems business and the expected launch of a new generation of monitors. Key risks include a potential slowdown in healthcare providers’ capex, regulatory approval delays, and dependence on a relatively narrow product portfolio.

Freedom Broker analysts set a 12-month fair price of $116. 

 

NorthEast Community Bancorp (NECB) is a regional bank focused on construction and residential real estate lending in New York and adjacent areas. Its investment appeal stems from a targeted footprint in highly liquid local housing markets where persistent supply shortages support steady credit demand and underpin strong loan portfolio quality. Profitability is a standout: NECB delivers robust net interest margins and returns on equity, exercises solid cost discipline, and sustains a strong capital base. Asset quality is likewise strong, with exceptionally low nonperforming loans and consistent organic capital generation without reliance on aggressive transactions or external financing. Despite these strengths, the shares trade at a meaningful discount to book value and to peer multiples, even as profitability metrics compare favorably. Key risks include potential net interest margin compression if the Fed eases policy, reliance on wholesale funding, and an elevated concentration in construction lending.

Freedom Broker analysts assign a 12‑month fair value (price target) of $30.